This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Equine Insulin (INS) ELISA Kit-Competitive
Product Overview
BioVenic Equine Insulin (INS) ELISA Kit-Competitive is designed for the quantitative determination of Equine Insulin (INS) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only. Sandwich ELISA assay kit targeting Equine Insulin (INS) is available. Please inquiry for more information.
Specifications
Target Information
Insulin, a peptide hormone, is synthesized by the beta cells within the pancreatic islets. It serves as the principal anabolic hormone in the body, orchestrating several critical functions. Firstly, insulin facilitates the absorption of glucose from the bloodstream into liver, fat, and skeletal muscle cells, thereby regulating blood sugar levels. Additionally, insulin plays a role in the metabolism of fats and proteins, promoting their storage and utilization. Insulin is encoded by the INS gene in horses. It is an essential hormone that controls blood glucose levels. Insulin resistance has profound consequences for the horse, with hyperinsulinemia implicated in the pathogenesis of laminitis - a common and potentially devastating condition.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.